	Molecular targets and the emerging role of copper radionuclides in prostate cancer theranostics. EJNMMI Res Rodrigues D, Fonseca AI, Moreira JN, Gomes C, Abrunhosa A. PMID: 41251982 [PubMed]
	Recurrent vertebrobasilar stroke in giant cell arteritis associated with progressive prostate carcinoma: a case report and literature review. Clin Rheumatol Bertens JPF, Oskam LC, van Bon L, van der Heijden CDCC. PMID: 41251917 [PubMed - as supplied by publisher]
	Patient Perspectives on Trust in Artificial Intelligence-Powered Tools in Prostate Cancer Diagnostics. Qual Health Res Berger SA, Håland E, Solbjør M. PMID: 41251145 [PubMed - as supplied by publisher]
	The CD8(+)/Foxp3(+) ratio, but not the number of OX40(+) TILs, is an independent predictor of tumor recurrence in non-muscle-invasive bladder cancer: a retrospective study. PeerJ Han K, Wang F, Wang R, Kong Q. PMID: 41250764 [PubMed - indexed for MEDLINE]
	Optimal Virtual-target Definition for Detecting Feeding Arteries of Renal Cell Carcinoma Using Automated Feeder-detection Software. Interv Radiol (Higashimatsuyama) Okamoto S, Matsui Y, Kawabata T, Tomita K, Munetomo K, Umakoshi N, Higaki F, Iguchi T, Hiraki T. PMID: 41250690 [PubMed]
	Anaplastic large cell lymphoma in the penis: a case report and review of literature. J Med Case Rep Al-Bitar A, Alomar Albrazi AA. PMID: 41250242 [PubMed - indexed for MEDLINE]
	The clinical study of preoperative normalized apparent diffusion coefficient of 3.0-T MRI in predicting muscular invasion of bladder cancer. BMC Med Imaging Wang Y, Xiao W, Zhang Z, Wu Y, Chen S, Zhang W, Luo M. PMID: 41249933 [PubMed - in process]
	Editorial Comment on Androgen Receptor Signaling Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study. Int J Urol Hashizume A. PMID: 41249868 [PubMed - as supplied by publisher]
	Low GATA3 predicts worse survival in penile cancer. Sci Rep Hrudka J, Prouzová Z, Mat, Hojný J, Kendall Bárt, , Zavillová N, Waldauf P. PMID: 41249810 [PubMed - indexed for MEDLINE]
	Therapeutic outcomes of Â²Â²âµAc/Â¹â·â·Lu-PSMA combination therapy in advanced metastatic Castration-Resistant prostate cancer: A systematic review and Meta-Analysis. Eur J Nucl Med Mol Imaging Belabaci Z, Brignoli G, Zilli T, Gruji, Mohamad I, Al-Ibraheem A, Shelan M, Afshar-Oromieh A. PMID: 41249719 [PubMed - as supplied by publisher]
	LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. Clin Exp Med Li Y, Zhao B, Gao W, Wu Y, Tian T, Zhao S, Zhang J, Li R, He S, Gong Y, Ma J, Li X. PMID: 41249576 [PubMed - indexed for MEDLINE]
	Predicting distant metastasis in early-onset kidney cancer using machine learning: a SEER database study with external validation. Clin Exp Med Yuan SP, Chen T, Chen R. PMID: 41249564 [PubMed - indexed for MEDLINE]
	A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter study. NPJ Digit Med Zang X, Xia Y, Xiao H, Luo H, Si M, Hou N, Haoni A, Chen T, Liu Z, Pu X, Zi X, Xu L, Zhu J, Xu Z, Wang J, Wang Z, Xia J, Cao D, Yin Y, Wang J, Wu X, Kong W, Huang J, Zhang J, Chen Y, Huang Y, Leung DK, Teoh JY, Wang K, Liang C, Zheng J, Yu Z, Zhai W. PMID: 41249481 [PubMed]
	Comparison of combined MRI-TRUS fusion targeted and systematic biopsy vs systematic biopsy alone for the detection of prostate cancer in the Chinese biopsy-naÃ¯ve patients: a prospective, single-center trial. Int J Surg Liu W, Kadier A, Tang C, Shen D, He Y, Zhu K, Xu G, Zhao B, Mao S, Guo C, Wei Q, Han D, Yang B, Yao X, Shen B. PMID: 41249016 [PubMed - as supplied by publisher]
	Correspondence: comment on "Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer". Int J Surg Chen X, Huang R. PMID: 41247995 [PubMed - as supplied by publisher]
	Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. Elife Chen L, Gu Y, Chen Y, Yu W, Zhou Y, Rong Z, Pang X. PMID: 41247789 [PubMed - indexed for MEDLINE]
	Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI - a comparative study. EJNMMI Res Grefve J, Strandberg SN, Jonsson J, Lindberg AK, Nilsson E, Bergh A, Söderkvist K, Karlsson CT, Nedar L, Løgager VB, Thimansson E, Trägårdh E, Bengtsson J, Hvittfeldt E, Axelsson J, Nyholm T, Riklund K, Sandgren K. PMID: 41247538 [PubMed]
	Computed tomography guided microwave ablation for the treatment of clinical T1a renal cell carcinoma: a comparison to robot-assisted laparoscopic partial nephrectomy. World J Urol Petersson RD, Bretlau T, Abbas M, Schou-Jensen KS, Thomsen FF. PMID: 41247513 [PubMed - indexed for MEDLINE]
	Hexaminolevulinate-enhanced photodynamic diagnosis in the management of non-muscle-invasive bladder cancer (NMIBC): theÂ influence of differing European health care payment systems onÂ the potential financial impact of adoption. J Med Econ Belsey J, Lapon J. PMID: 41247459 [PubMed - indexed for MEDLINE]
	Urinary DNA Methylation Profiling Improves Discrimination of Prostate Cancer Across PSA-Defined Risk Strata. Biochem Genet Zhu W, Qian Y, Zhao X, Fang Z, Luo Z, Xie W, Cao Y, Chen W, Fu H, Peng J, Zhang L, Li J, Lei S, Jin J, Gong Z, Zhang D, He Y. PMID: 41247441 [PubMed - as supplied by publisher]

Articles 1 - 20 / 171764

Page 1 of 8589



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy